Genaera to begin late-stage clinical trials for squalamine

April 24, 2004

Genaera Corp., Plymouth Meeting, PA, announced late last week that itexpects to begin late-stage clinical trials by early 2005 of its experimentaldrug squalamine to treat age-related macular degeneration (AMD).